BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12921954)

  • 1. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
    Ramírez M; Díaz MA; Madero L; Bueren JA
    Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
    Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
    Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors.
    Benito AI; Bryant E; Loken MR; Sale GE; Nash RA; John Gass M; Deeg HJ
    Leuk Res; 2003 May; 27(5):425-36. PubMed ID: 12620294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
    Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
    Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
    Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
    Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
    N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP; Shao L; Billman GF; Yu J
    Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of residual tumor cells in the bone marrow of children with B-linear acute lymphoblastic leukemia by flow cytofluorometry].
    Belevtsev MB; Savitskiĭ VP; Savva NN; Petina OV; Migal' NV; Aleĭnikova OV
    Klin Lab Diagn; 2006 Oct; (10):42-6. PubMed ID: 17144545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells.
    Lin C; Chen S; Yang L; Tan Y; Bai X; Li Y
    Hematology; 2007 Aug; 12(4):325-30. PubMed ID: 17654060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
    Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
    Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice.
    Turner CW; Archer DR; Wong J; Yeager AM; Fleming WH
    Br J Haematol; 1998 Nov; 103(2):326-34. PubMed ID: 9827901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human AML cells in NOD/SCID mice: engraftment potential and gene expression.
    Lumkul R; Gorin NC; Malehorn MT; Hoehn GT; Zheng R; Baldwin B; Small D; Gore S; Smith D; Meltzer PS; Civin CI
    Leukemia; 2002 Sep; 16(9):1818-26. PubMed ID: 12200698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.
    Kamel-Reid S; Letarte M; Sirard C; Doedens M; Grunberger T; Fulop G; Freedman MH; Phillips RA; Dick JE
    Science; 1989 Dec; 246(4937):1597-600. PubMed ID: 2595371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
    le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
    Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.